Kaufman Daniel Louis 13D/13G Filings for Abeona Therapeutics Inc. (ABEO)

Kaufman Daniel Louis 13D and 13G filings for Abeona Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-03-27
2:48 pm
Purchase
2026-03-2613GABEONA THERAPEUTICS INC NE
ABEO
Kaufman Daniel Louis2,943,629
5.160%
2,943,629increase
(New Position)
Filing